Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EOIPB for Pain Control in Laparoscopic Cholecystectomy
NCT06541613Phase 4Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Apr 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in pain, sponsored by Theodor Bilharz Research Institute. Primary endpoint: Total Morphine Consumption. Started Apr 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06541613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06541613.